149
Views
0
CrossRef citations to date
0
Altmetric
Articles

Inhibitory control is associated with medication adherence in young HIV patients without comorbidities

, , &

References

  • Anand, P., Springer, S. A., Copenhaver, M. M., & Altice, F. L. (2010). Neurocognitive impairment and HIV risk factors: A reciprocal relationship. AIDS and Behavior, 14(6), 1213–1226. https://doi.org/10.1007/s10461-010-9684-1
  • Andrade, A. S. A., Deutsch, R., A Celano, S., Duarte, N. A., Marcotte, T. D., Umlauf, A., Atkinson, J. H., McCutchan, J. A., Franklin, D., Alexander, T. J., McArthur, J. C., Marra, C., Grant, I., & Collier, A. C. (2013). Relationships among neurocognitive status, medication adherence measured by pharmacy refill records, and virologic suppression in HIV-infected persons. Journal of Acquired Immune Deficiency Syndromes, 62(3), 282–292. https://doi.org/10.1097/QAI.0b013e31827ed678
  • Babson, K. A., Heinz, A. J., & Bonn-Miller, M. O. (2013). HIV medication adherence and HIV symptom severity: The roles of sleep quality and memory. AIDS Patient Care and STDs, 27(10), 544–552. https://doi.org/10.1089/apc.2013.0221
  • Barfod, T. S., Sorensen, H. T., Nielsen, H., Rodkjaer, L., & Obel, N. (2006). Simply forgot’ is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence. HIV Medicine, 7(5), 285–290. https://doi.org/10.1111/j.1468-1293.2006.00387.x
  • Becker, B. W., Thames, A. D., Woo, E., Castellon, S. A., & Hinkin, C. H. (2011). Longitudinal change in cognitive function and medication adherence in HIV-infected adults. AIDS and Behavior, 15(8), 1888–1894. https://doi.org/10.1007/s10461-011-9924-z
  • Brock, L. L., Brock, C. D., & Thiedke, C. C. (2011). Executive function and medical non-adherence: A different perspective. International Journal of Psychiatry in Medicine, 42(2), 105–115. https://doi.org/10.2190/PM.42.2.a
  • Burgess, P. W., Alderman, N., Forbes, C., Costello, A., Coates, L. M.-A., Dawson, D. R., Anderson, N. D., Gilbert, S. J., Dumontheil, I., & Channon, S. (2006). The case for the development and use of “ecologically valid” measures of executive function in experimental and clinical neuropsychology. Journal of the International Neuropsychological Society: JINS, 12(2), 194–209. https://doi.org/10.1017/S1355617706060310
  • Burgess, P. W., & Shallice, T. (1997). Hayling and Brixton Tests. Pearson.
  • Burgess, P. W., Veitch, E., de Lacy Costello, A., & Shallice, T. (2000). The cognitive and neuroanatomical correlates of multitasking. Neuropsychologia, 38(6), 848–863. https://doi.org/10.1016/S0028-3932(99)00134-7
  • Byerly, M. J., Nakonezny, P. A., & Rush, A. J. (2008). The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Schizophrenia Research, 100(1–3), 60–69. https://doi.org/10.1016/j.schres.2007.12.470
  • Caballero, J., Ownby, R. L., Jacobs, R. J., Thomas, J. E., & Schweizer, M. S. (2019). Association between cognitive tests and antiretroviral medication adherence in older adults with HIV. Annals of Pharmacotherapy, 53(2), 151–158. https://doi.org/10.1177/1060028018798327
  • Chang, L., Ernst, T., Witt, M. D., Ames, N., Gaiefsky, M., & Miller, E. (2002). Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naïve HIV patients. NeuroImage, 17(3), 1638–1648. https://doi.org/10.1006/nimg.2002.1254
  • Cody, S. L., & Vance, D. E. (2016). The neurobiology of HIV and its impact on cognitive reserve: A review of cognitive interventions for an aging population. Neurobiology of Disease, 92(Pt B), 144–156. https://doi.org/10.1016/j.nbd.2016.01.011
  • Culig, J., & Leppée, M. (2014). From Morisky to Hill-Bone: Self-reports scales for measuring adherence to medication. Collegium Antropologicum, 38(1), 55–62.
  • Delis, D. C., Kaplan, E., & Kramer, J. H. (2001). Delis-Kaplan Executive Function System (D-KEFS). Pearson.
  • Ettenhofer, M. L., Foley, J., Castellon, S. A., & Hinkin, C. H. (2010). Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS. Neurology, 74(15), 1217–1222. https://doi.org/10.1212/WNL.0b013e3181d8c1ca
  • Ettenhofer, M. L., Hinkin, C. H., Castellon, S. A., Durvasula, R., Ullman, J., Lam, M., Myers, H., Wright, M. J., & Foley, J. (2009). Aging, neurocognition, and medication adherence in HIV infection. The American Journal of Geriatric Psychiatry, 17(4), 281–290. https://doi.org/10.1097/JGP.0b013e31819431bd
  • Ghafouri, M., Amini, S., Khalili, K., & Sawaya, B. E. (2006). HIV-1 associated dementia: Symptoms and causes. Retrovirology, 3, 28. https://doi.org/10.1186/1742-4690-3-28
  • Gorman, A. A., Foley, J. M., Ettenhofer, M. L., Hinkin, C. H., & van Gorp, W. G. (2009). Functional consequences of HIV-associated neuropsychological impairment. Neuropsychology Review, 19(2), 186–203. https://doi.org/10.1007/s11065-009-9095-0
  • Heaton, R. K., Franklin, D. R., Ellis, R. J., McCutchan, J. A., Letendre, S. L., Leblanc, S., Corkran, S. H., Duarte, N. A., Clifford, D. B., Woods, S. P., Collier, A. C., Marra, C. M., Morgello, S., Mindt, M. R., Taylor, M. J., Marcotte, T. D., Atkinson, J. H., Wolfson, T., Gelman, B. B., … Grant, I. (2011). HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: Differences in rates, nature, and predictors. Journal of Neurovirology, 17(1), 3–16. https://doi.org/10.1007/s13365-010-0006-1
  • Heaton, R. K., Marcotte, T. D., Mindt, M. R., Sadek, J., Moore, D. J., Bentley, H., McCutchan, J. A., Reicks, C., & Grant, I. (2004). The impact of HIV-associated neuropsychological impairment on everyday functioning. Journal of the International Neuropsychological Society: JINS, 10(3), 317–331. https://doi.org/10.1017/S1355617704102130
  • Hinkin, C. H., Castellon, S. A., Durvasula, R. S., Hardy, D. J., Lam, M. N., Mason, K. I., Thrasher, D., Goetz, M. B., & Stefaniak, M. (2002). Medication adherence among HIV + adults: Effects of cognitive dysfunction and regimen complexity. Neurology, 59(12), 1944–1950. https://doi.org/10.1212/01.wnl.0000038347.48137.67
  • Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N., & Stefaniak, M. (2004). Medication adherence in HIV-infected adults: Effect of patient age, cognitive status, and substance abuse. AIDS, 18(Supplement 1), 19–25. https://doi.org/10.1097/00002030-200401001-00004
  • Kamat, R., Woods, S. P., Marcotte, T. D., Ellis, R. J., & Grant, I. (2012). Implications of apathy for everyday functioning outcomes in persons living with HIV infection. Archives of Clinical Neuropsychology: The Official Journal of the National Academy of Neuropsychologists, 27(5), 520–531. https://doi.org/10.1093/arclin/acs055
  • Kosmidis, M. H., Bozikas, B. P., Vlachou, C. E., & Tsapkini, K. (2012). Neuropsychological Batery of School of Psychology. Aristotle University of Thessaloniki.
  • Kramer, J. H., Mungas, D., Possin, K. L., Rankin, K. P., Boxer, A. L., Rosen, H. J., Bostrom, A., Sinha, L., Berhel, A., & Widmeyer, M. (2014). NIH Examiner: Conceptualization and development of an executive function battery. Journal of the International Neuropsychological Society: JINS, 20(1), 11–19. https://doi.org/10.1017/S1355617713001094
  • Kuper, M., Rabe, K., Esser, S., Gizewski, E. R., Husstedt, I. W., Maschke, M., & Obermann, M. (2011). Structural gray and white matter changes in patients with HIV. Journal of Neurology, 258(6), 1066–1075. https://doi.org/10.1007/s00415-010-5883-y
  • Lezak, M. D., Howieson, D. B., Bigler, E. D., & Tranel, D. (2012). Neuropsychological Assessment. (5th ed.). Oxford University Press.
  • Logan, G. D., & Cowan, W. B. (1984). On the ability to inhibit thought and action: A theory of an act of control. Psychological Review, 91(3), 295–327. https://doi.org/10.1037/0033-295X.91.3.295
  • Lovejoy, T. I., & Suhr, J. A. (2009). The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: A systematic review. Journal of Behavioral Medicine, 32(5), 389–405. https://doi.org/10.1007/s10865-009-9212-9
  • Martin, E. M., Pitrak, D. L., Weddington, W., Rains, N. A., Nunnally, G., Nixon, H., Grbesic, S., Vassileva, J., & Bechara, A. (2004). Cognitive impulsivity and HIV serostatus in substance dependent males. Journal of the International Neuropsychological Society: JINS, 10(7), 931–938. https://doi.org/10.1017/s1355617704107054
  • Martyr, A., Boycheva, E., & Kudlicka, A. (2019). Assessing inhibitory control in early-stage Alzheimer’s and Parkinson’s disease using the Hayling Sentence Completion Test. Journal of Neuropsychology, 13(1), 67–81. https://doi.org/10.1111/jnp.12129
  • Meade, C. S., Conn, N. A., Skalski, L. M., & Safren, S. A. (2011). Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence. Journal of Behavioral Medicine, 34(2), 128–138. https://doi.org/10.1007/s10865-010-9293-5
  • Miyake, A., Friedman, N. P., Emerson, M. J., Witzki, A. H., Howerter, A., & Wager, T. D. (2000). The unity and diversity of executive functions and their contributions to complex “Frontal Lobe” tasks: A latent variable analysis. Cognitive Psychology, 41(1), 49–100. https://doi.org/10.1006/cogp.1999.0734
  • Morisky, D. E., Ang, A., Krousel-Wood, M., & Ward, H. J. (2008). Predictive validity of a medication adherence measure in an outpatient setting. The Journal of Clinical Hypertension, 10(5), 348–354. https://doi.org/10.1111/j.1751-7176.2008.07572.x
  • Morisky, D. E., Green, L. W., & Levine, D. M. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 24(1), 67–74. https://doi.org/10.1097/00005650-198601000-00007
  • Nachega, J. B., Marconi, V. C., van Zyl, G. U., Gardner, E. M., Preiser, W., Hong, S. Y., Mills, E. J., & Gross, R. (2011). HIV treatment adherence, drug resistance, virologic failure: Evolving concepts. Infectious Disorders Drug Targets, 11(2), 167–174. https://doi.org/10.2174/187152611795589663
  • Nigg, J. T. (2000). On inhibition/disinhibition in developmental psychopathology: Views from cognitive and personality psychology and a working inhibition taxonomy. Psychological Bulletin, 126(2), 220–246. https://doi.org/10.1037/0033-2909.126.2.220
  • Norman, D. A., & Shallice, T. (1986). Attention to action consciousness and self-regulation (pp. 1–18). Springer.
  • Odhuba, R. A., van den Broek, M. D., & Johns, L. C. (2005). Ecological validity of measures of executive functioning. The British Journal of Clinical Psychology, 44(Pt 2), 269–278. https://doi.org/10.1348/014466505X29431
  • Panos, S. E., Del Re, A. C., Thames, A. D., Arentsen, T. J., Patel, S. M., Castellon, S. A., Singer, E. J., & Hinkin, C. H. (2014). The impact of neurobehavioral features on medication adherence in HIV: Evidence from longitudinal models. AIDS Care, 26(1), 79–86. https://doi.org/10.1080/09540121.2013.802275
  • Pearce, B., Cartwright, J., Cocks, N., & Whitworth, A. (2016). Inhibitory control and traumatic brain injury: The association between executive control processes and social communication deficits. Brain Injury, 30(13–14), 1708–1717. https://doi.org/10.1080/02699052.2016.1202450
  • Pearson, C. R., Simoni, J. M., Hoff, P., Kurth, A. E., & Martin, D. P. (2007). Assessing antiretroviral adherence via electronic drug monitoring and self-report: An examination of key methodological issues. AIDS and Behavior, 11(2), 161–173. https://doi.org/10.1007/s10461-006-9133-3
  • Reitan, R. M. (1958). Validity of the trail making test as an indicator of organic brain damage. Perceptual and Motor Skills, 8(3), 271–276. https://doi.org/10.2466/pms.1958.8.3.271
  • Roca, M., Parr, A., Thompson, R., Woolgar, A., Torralva, T., Antoun, N., Manes, F., & Duncan, J. (2010). Executive function and fluid intelligence after frontal lobe lesions. Brain: A Journal of Neurology, 133(Pt 1), 234–247. https://doi.org/10.1093/brain/awp269
  • Rumbaugh, J. A., & Tyor, W. (2015). HIV-associated neurocognitive disorders: Five new things. Neurology. Clinical Practice, 5(3), 224–231. https://doi.org/10.1212/CPJ.0000000000000117
  • Semple, S. J., Zians, J., Grant, I., & Patterson, T. L. (2006). Sexual compulsivity in a sample of HIV-positive methamphetamine-using gay and bisexual men. AIDS and Behavior, 10(5), 587–598. https://doi.org/10.1007/s10461-006-9127-1
  • Simoni, J. M., Huh, D., Wang, Y., Wilson, I. B., Reynolds, N. R., Remien, R. H., Goggin, K., Gross, R., Rosen, M. I., Schneiderman, N., Arnsten, J., Golin, C. E., Erlen, J. A., Bangsberg, D. R., & Liu, H. (2014). The validity of self-reported medication adherence as an outcome in clinical trials of adherence-promotion interventions: Findings from the MACH14 study. AIDS and Behavior, 18(12), 2285–2290. https://doi.org/10.1007/s10461-014-0905-x
  • Solomon, T. M., & Halkitis, P. N. (2008). Cognitive executive functioning in relation to HIV medication adherence among gay, bisexual, and other men who have sex with men. AIDS and Behavior, 12(1), 68–77. https://doi.org/10.1007/s10461-007-9273-0
  • Thames, A. D., Kim, M. S., Becker, B. W., Foley, J. M., Hines, L. J., Singer, E. J., Heaton, R. K., Castellon, S. A., & Hinkin, C. H. (2011). Medication and finance management among HIV-infected adults: The impact of age and cognition. Journal of Clinical and Experimental Neuropsychology, 33(2), 200–209. https://doi.org/10.1080/13803395.2010.499357
  • Vance, D. E., McDougall, G. J., Jr., Wilson, N., Debiasi, M. O., & Cody, S. L. (2014). Cognitive consequences of aging with HIV: Implications for neuroplasticity and rehabilitation. Topics in Geriatric Rehabilitation, 30(1), 35–45. https://doi.org/10.1097/TGR.0000000000000002
  • Waldrop-Valverde, D., Jones, D. L., Jayaweera, D., Gonzalez, P., Romero, J., & Ownby, R. L. (2009). Gender differences in medication management capacity in HIV infection: The role of health literacy and numeracy. AIDS and Behavior, 13(1), 46–52. https://doi.org/10.1007/s10461-008-9425-x
  • Waldrop-Valverde, D., Jones, D. L., Weiss, S., Kumar, M., & Metsch, L. (2008). The effects of low literacy and cognitive impairment on medication adherence in HIV-positive injecting drug users. AIDS Care, 20(10), 1202–1210. https://doi.org/10.1080/09540120801927017
  • Walker, K. A., & Brown, G. G. (2018). HIV-associated executive dysfunction in the era of modern antiretroviral therapy: A systematic review and meta-analysis. Journal of Clinical and Experimental Neuropsychology, 40(4), 357–376. https://doi.org/10.1080/13803395.2017.1349879
  • Wechsler, D. (2008). Wechsler adult intelligence scale (4th ed.). Pearson.
  • Woods, S. P., Moore, D. J., Weber, E., & Grant, I. (2009). Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychology Review, 19(2), 152–168. https://doi.org/10.1007/s11065-009-9102-5
  • Woods, S. P., Moran, L. M., Carey, C. L., Dawson, M. S., Iudicello, J. E., Gibson, S., Grant, I., & Atkinson, J. H. (2008). Prospective memory in HIV infection: Is “remembering to remember” a unique predictor of self-reported medication management? Archives of Clinical Neuropsychology: The Official Journal of the National Academy of Neuropsychologists, 23(3), 257–270. https://doi.org/10.1016/j.acn.2007.12.006
  • Zogg, J. B., Woods, S. P., Sauceda, J. A., Wiebe, J. S., & Simoni, J. M. (2012). The role of prospective memory in medication adherence: A review of an emerging literature. Journal of Behavioral Medicine, 35(1), 47–62. https://doi.org/10.1007/s10865-011-9341-9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.